List view / Grid view
22 July 2016 | By Niamh Louise Marriott, Digital Content Producer
ReNeuron Group plc, a UK-based stem cell research company, today revealed further key pre-clinical efficacy data with its human retinal progenitor cells...
9 June 2016 | By Victoria White, Digital Content Producer
ReNeuron selected glioblastoma multiforme based on evidence of tumour-inhibiting activity from early preclinical studies with the exosome technology...
12 January 2016 | By Victoria White
ReNeuron is researching the therapeutic potential of exosomes derived from its proprietary stem cell lines. The Company is also exploring the potential of its exosomes as a delivery system for gene therapy treatments...
17 December 2015 | By Victoria White
The Scientific Advisory Board comprises nine leading academics and industry executives with a world-class breadth of expertise across the Company’s areas of operation...
22 June 2015 | By Victoria White
ReNeuron Group has extended its ongoing research collaboration with Australia-based Benitec Biopharma following positive results in early studies...
5 May 2015 | By Victoria White
ReNeuron has received approval from the FDA to commence a Phase I/II clinical trial in the US with its hRPC therapy candidate for retinitis pigmentosa...
